-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TOZKBrB4yfpPwMHDC/MeQtxJ+S9snCFdI2DDRETuqCPZnvzcWCqEFOcDEOUOsryg SpNkLk2nFjGBKLhyKLVdVA== 0001179110-10-010647.txt : 20100616 0001179110-10-010647.hdr.sgml : 20100616 20100616190104 ACCESSION NUMBER: 0001179110-10-010647 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100614 FILED AS OF DATE: 20100616 DATE AS OF CHANGE: 20100616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brinkley David L CENTRAL INDEX KEY: 0001302445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 10901686 MAIL ADDRESS: STREET 1: 901 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0303 4 2010-06-14 0 0001080014 THERAVANCE INC THRX 0001302445 Brinkley David L THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Head of Business Dev. Common Stock 2010-06-14 4 M 0 33516 8.525 A 68754 D Common Stock 2010-06-14 4 S 0 33516 15.65 D 35238 D Common Stock 2010-06-15 4 M 0 33516 8.525 A 68754 D Common Stock 2010-06-15 4 S 0 33516 15.45 D 35238 D Stock Option (Right to Buy) 8.525 2010-06-14 4 M 0 33516 0 D 2010-06-17 Common Stock 33516 33516 D Stock Option (Right to Buy) 8.525 2010-06-15 4 M 0 33516 0 D 2010-06-17 Common Stock 33516 0 D This transaction was executed in multiple trades at prices ranging from $15.32 to $15.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $15.38 to $15.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Immediately exercisable. Dispositions made pursuant to a plan intended to comply with Rule 10b5-1(c). David Brinkley 2010-06-16 -----END PRIVACY-ENHANCED MESSAGE-----